Tim Wilsdon has 30 years’ experience in life sciences policy consulting. He is a Vice President in CRA’s Life Sciences Practice and is responsible for leading the Policy Team. Tim has completed studies for the European Commission (including DG GROW and DG TRADE), the pharmaceutical industry (through EFPIA, PhRMA, and country associations such as Innovative Medicines Canada, ABPI, vFA, and LIF), and organisations such as PAHO and the Wellcome Trust on how healthcare markets could be reformed to improve efficiency. He has undertaken recent assessments of the evolution of European competitiveness, the introduction of Joint Clinical Assessments, international reference pricing, early access agreements, and managed entry agreements, as well as work across many therapeutic areas.